Skip to main content
. 2023 Apr 4;55(4):1210–1221. doi: 10.4143/crt.2022.1633

Fig. 2.

Fig. 2

Kaplan-Meier survival analysis for disease-free survival according to pre-NACT human epidermal growth factor receptor 2 (HER2) status (A) and pathological complete response (pCR) status (B) in all, hormone receptor (HR)–negative (C), and HR-positive (D) patients.